Sanjay Shukla - President and CEO, Director at aTYR PHARMA INC

Insider Transactions and Holdings

Entity Type
Individual
Role
President and CEO, Director
Stock Symbol
ATYR on Nasdaq
All Insider Reports
All Insider Reports

Sanjay Shukla - trading volume in the past year for aTYR PHARMA INC

Holdings reported by Sanjay Shukla for aTYR PHARMA INC

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 137K $247K $1.81 May 31, 2024 Direct
Restricted Stock Unit 20.8K $35.1K $1.69 Feb 5, 2024 Direct Common Stock
Employee Stock Option (right to buy) 600K Jan 5, 2024 Direct Common Stock

Transactions reported by Sanjay Shukla for aTYR PHARMA INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.